- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.11. | Novartis reports positive phase 3 results for Cosentyx in polymyalgia rheumatica | ||
| 03.11. | Uniphar announces US expansion and company integration | ||
| 03.11. | Turning connection into action: VML Health's first Patient Advocacy Summit ignites collaboration in Berlin | ||
| 03.11. | Creativity cages | ||
| 31.10. | Novartis presents new positive data for rheumatic autoimmune disease treatment | ||
| 31.10. | Lilly to invest $1.2bn in Puerto Rico manufacturing site | ||
| 31.10. | A quest for the crown: ruling digital relevance in the age of LLMs | ||
| 31.10. | The three non-negotiable pillars of Alzheimer's blood testing | ||
| 30.10. | Kyowa Kirin and University Hospitals Birmingham announce new survival data in rare disease study | ||
| 30.10. | UCB's Finteplap shows positives results for Lennox-Gastaut syndrome | ||
| 30.10. | Navigating the 'Patient Metro' - a journey full of insights | ||
| 29.10. | FDA Fast Track designation given to Enterome's follicular lymphoma treatment | ||
| 29.10. | Medicus Pharma recruits first patient in cancer patch trial | ||
| 29.10. | Aspire Pharma - enhancing the patient experience through stakeholder engagement | ||
| 28.10. | GSK's Blenrep approved by FDA for multiple myeloma | ||
| 28.10. | Medherant announces positive phase 1 results for testosterone patch for women | ||
| 28.10. | From insight to impact: strengthening stakeholder engagement across the patient journey | ||
| 27.10. | Novartis to acquire Avidity Biosciences in deal worth $12bn | ||
| 27.10. | BMS, Macmillan and 11 NHS Trusts publish report on cancer treatment prehabilitation | ||
| 24.10. | Corcept Therapeutics reports positive phase 3 results in ovarian cancer treatment | ||
| 24.10. | ProImmune expands into new global headquarters in Oxford | ||
| 23.10. | Ipsen to acquire ImCheck Therapeutics in a deal worth up to €1bn | ||
| 23.10. | Excellence in Healthcare Partnerships (EHP) Awards Networking Event | ||
| 22.10. | ViiV Healthcare receives NICE recommendation for HIV prevention therapy | ||
| 22.10. | Aqilion announces positive results from eosinophilic esophagitis treatment study |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .